Company page

Eirgenix, Inc.

Eirgenix, Inc. is a publicly traded company on the Taiwan stock market under the ticker 6589, with a market capitalization of approximately 448.17 million USD. The company focuses on biopharmaceutical development and aims to provide innovative therapies. Eirgenix is committed to advancing healthcare solutions through its research and development efforts.